跳转至内容
Merck
  • Human carboxylesterases and their role in xenobiotic and endobiotic metabolism.

Human carboxylesterases and their role in xenobiotic and endobiotic metabolism.

Journal of biochemical and molecular toxicology (2007-10-16)
Matthew K Ross, J Allen Crow
摘要

Carboxylesterases (CEs) are traditionally regarded as xenobiotic metabolizing enzymes that hydrolyze esterified xenobiotics to alcohol and carboxylic acid products. However, there is a growing appreciation for the role of CEs in the processing of endobiotics, including cholesteryl esters and triacylglycerols. Human liver microsomes (HLMs) are often used in reaction phenotyping studies to discern interindividual variability in xenobiotic metabolism. The two major CE isoforms expressed in human liver are hCE1 and hCE2. These two isoforms are different gene products. We have begun studies to evaluate the CE phenotype'' of human liver samples, i.e. to determine both the levels of hCE1 and hCE2 protein and the hydrolytic activity of each. We have previously shown that there is little variation in hCE1 protein expression in HLM samples from 11 individuals [a 1.3-fold difference between the highest and lowest individuals; coefficient of variation (CV), 9%]. hCE2 protein expression in individual HLMs is only slightly more variable than hCE1 (2.3-fold difference between the highest and lowest individuals; CV, 36%). However, hCE1 protein is found in 46-fold higher amounts in HLMs than hCE2 protein (64.4 +/- 16.5 microg hCE1/mg microsomal protein compared to 1.4 +/- 0.2 microg hCE2/mg microsomal protein). The hydrolytic activity specifically attributable to hCE1 and hCE2 in individual HLMs was measured using bioresmethrin (a pyrethroid insecticide hydrolyzed specifically by hCE1, but not by hCE2) and procaine (an analgesic drug hydrolyzed by hCE2, but not by hCE1). The hydrolytic activity of individual HLMs toward bioresmethrin and procaine did not correlate with the protein content of hCE1 and hCE2. Thus, the mere abundance of CE proteins is not a good predictor of CE activity in HLMs. Identification of the factors that lead to altered CE activities in HLMs will be important to characterize since several pharmaceutical agents, environmental toxicants, and endobiotics are metabolized by these enzymes.

材料
货号
品牌
产品描述

Sigma-Aldrich
脂肪酶 来源于皱褶假丝酵母, Type VII, ≥700 unit/mg solid
Sigma-Aldrich
脂肪酶 来源于猪胰腺, Type II, ≥125 units/mg protein (using olive oil (30 min incubation)), 30-90 units/mg protein (using triacetin)
Sigma-Aldrich
脂肪酶丙烯酸树脂, ≥5,000 U/g, recombinant, expressed in Aspergillus niger
Sigma-Aldrich
脂肪酶 来源于猪胰腺, Type VI-S, ≥20,000 units/mg protein, lyophilized powder
Sigma-Aldrich
重组脂肪酶 B 南极假丝酵母 来源于米曲霉, powder, beige, ~9 U/mg
Sigma-Aldrich
脂肪酶 来源于黑曲霉, powder (fine), ~200 U/g
Sigma-Aldrich
脂肪酶 来源于皱褶假丝酵母, lyophilized powder, ≥40,000 units/mg protein
Sigma-Aldrich
固定化脂肪酶 来源于南极假丝酵母, beads, slightly brown, >2 U/mg
Sigma-Aldrich
脂肪酶 来源于念珠菌 属, recombinant, expressed in Aspergillus niger
Sigma-Aldrich
脂肪酶 来源于米赫根毛霉, ≥20,000 U/g
Sigma-Aldrich
脂肪酶 来源于洋葱假单胞菌, powder, light beige, ≥30 U/mg
Sigma-Aldrich
脂肪酶 来源于小麦胚芽, Type I, lyophilized powder, 5-15 units/mg solid
Sigma-Aldrich
脂肪酶 来源于米根霉, powder (fine), ~10 U/mg
Sigma-Aldrich
脂肪酶 来源于米曲霉, lyophilized, powder, white, ~50 U/mg
Sigma-Aldrich
脂肪酶 来源于假单胞菌 属, Type XIII, lyophilized powder, ≥15 units/mg solid
Sigma-Aldrich
脂肪酶 来源于皱褶假丝酵母, powder, yellow-brown, ≥2 U/mg
Sigma-Aldrich
脂肪酶 来源于皱褶假丝酵母, lyophilized, powder (fine), 15-25 U/mg
Sigma-Aldrich
脂肪酶 来源于米黑毛霉菌, lyophilized powder, ≥4,000 units/mg solid (using olive oil)
Sigma-Aldrich
脂肪酶 来源于米黑毛霉菌, powder, slightly brown, ~1 U/mg
Sigma-Aldrich
脂肪酶 来源于猪胰腺 来源于雪白根霉菌, powder (fine), ≥1.5 U/mg
Sigma-Aldrich
脂肪酶 来源于爪哇毛霉菌, lyophilized powder, ≥300 units/mg solid (using olive oil)
Sigma-Aldrich
南极假丝酵母脂肪酶A,重组 来源于米曲霉, powder, beige, ~2 U/mg